What if artificial intelligence could help spot oral cancer earlier — before symptoms even appear?At the University of Maryland School of Dentistry, Ahmed Sultan is leading NIH-funded research to develop AI tools that detect early-stage oral cancer, especially in communities with limited access to care. This work combines innovation and equity to save lives through faster, more accurate diagnosis.🔗 Learn more: https://vist.ly/3n5gjp9#OralCancer #EarlyDetection #AIHealthTech #AhmedSultan #NIHResearch #HealthcareEquity #MedicalInnovation #BreakthroughsCantWait #CancerScreening #Science #Dentistry

Metformin was designed to treat type 2 diabetes.Now, Abraham Schneider, DDS, PhD, at @UMSOD is uncovering how this affordable medication could support craniofacial bone regeneration — helping patients heal after oral trauma, surgery, or disease.Supported by the National Institutes of Health, his work represents a potential breakthrough in non-invasive bone repair and oral health innovation.https://umaryland.edu/breakthroughs#BreakthroughsCantWaitUMB #NIHResearch #MetforminScience #BoneHealing #DentalInnovation #MedicalResearch #Science #Dentistry #DentalSurgery

Could an affordable diabetes drug change how we rebuild bone after trauma?Abraham Schneider, DDS, PhD, at the University of Maryland School of Dentistry is investigating how metformin supports bone regeneration — not just in theory, but as a real, low-cost solution for treating injuries to the face and jaw.Supported by the National Institutes of Health, this research opens the door to non-invasive, drug-based alternatives to traditional bone grafting techniques — a promising breakthrough for oral surgeons and trauma recovery specialists.🔗 Learn more: https://vist.ly/3n4yu4g #BreakthroughsCantWait #BoneHealing #NIHResearch #DentalInnovation #MetforminScience #OralHealthCare #Research #Science #MedicalBreakthroughs

Could a pill designed for blood sugar control help rebuild the human jaw?That’s one of the questions driving Abraham Schneider, DDS, PhD, associate professor and chair of the Department of Oncology and Diagnostic Sciences at the University of Maryland School of Dentistry. With support from the National Institutes of Health, Schneider is studying how metformin, a widely used and affordable drug for type 2 diabetes, might also help regenerate craniofacial bone — offering a new, cost-effective strategy to treat damage caused by trauma or disease.“We are trying to regenerate a craniofacial bone that is affected by several conditions, including periodontal disease and trauma,” Schneider said. “So, we are trying to look for new ways of regenerating bone.”#OralCancer #DentalResearch #BreakthroughsCantWait #NIHResearch #HeadNeckCancer #CraniofacialBiology #CancerTreatment #UniversityOfMaryland #MedicalBreakthroughs

What if we could regenerate bone using a medication already on the market?At the University of Maryland, Baltimore, researchers are exploring how metformin — a drug commonly used to treat diabetes — could be repurposed to stimulate bone growth and healing.This is just one of many NIH-funded breakthroughs at UMB with the power to transform medicine and save lives.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #BoneRegeneration #MetforminResearch #DiabetesDrugInnovation #MedicalBreakthroughs #UMBResearch #NIHfunding #TissueEngineering

Congratulations to the University of Maryland, Baltimore Class of 2025. This year, we present Seven Students, One Conversations, speaking to graduates from each of UMB's seven schools.Provost and Executive Vice President Roger Ward, EdD, JD, MSL, MPA, asks these students about their experiences at UMB as they pause, reflect and look forward to their futures after graduation.